DNCA Finance’s AstraZeneca AZN Stock Holding History

DNCA Finance’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109M	Buy	581,859 +28,970	+5%	+$5.45M	5.28%	3
2026 Q1	$107M	Buy	+552,889	New	+$107M	6.13%	2

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DNCA Finance's AZN Position: Q2 2026 in Review

DNCA Finance increased its AstraZeneca (AZN) stake by 5.2% in Q2 2026, buying an estimated $5.45M and bringing the position to 581,859 shares worth $109M. The position accounts for 5.28% of the portfolio, ranked #3.

DNCA Finance first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

DNCA Finance held 581,859 shares of AstraZeneca worth $109M as of Q2 2026.
DNCA Finance bought 28,970 AstraZeneca shares in Q2 2026, an estimated $5.45M.
AstraZeneca made up 5.28% of DNCA Finance's portfolio in Q2 2026, its #3 holding.
DNCA Finance first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on DNCA Finance's 13F filing for Q2 2026, filed 13 Aug 2026.